457 バイト追加
、 2019年12月23日 (月) 00:42
{{Quote
|content=Modjarrad K, Roberts C, Mills K, et. al. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet Infectious Diseases. 2019;19(9):1013-1022. [cited 2019Oct11] Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30266-X/fulltext
}}
{{Collapse
|title=MERSプラスミドワクチン phase 1
|content=
}}